Patents by Inventor Stephane Bejanin

Stephane Bejanin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN cDNAs AND PROTEINS AND USES THEREOF
    Publication number: 20080026427
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Application
    Filed: September 26, 2007
    Publication date: January 31, 2008
    Applicant: Serono Genetics Institute S.A.
    Inventors: STEPHANE BEJANIN, Hiroaki Tanaka
  • HUMAN CDNAS AND PROTEINS AND USES THEREOF
    Publication number: 20070292885
    Abstract: The invention provides polynucleotides and polypeptides encoding an isolated amyloid inhibitor protein (APIP) and compositions thereof. The polypeptides of the subject invention can be used to inhibit the catabolism or sequential cleavage of amyloid beta precursor protein (APP) by sequential cleavage of APP by beta secretase and gamma secretase.
    Type: Application
    Filed: July 31, 2007
    Publication date: December 20, 2007
    Inventors: STEPHANE BEJANIN, Hiroaki Tanaka
  • ?-Secretase variant
    Patent number: 7291495
    Abstract: The invention provides polynucleotides and polypeptides encoding an isolated amyloid inhibitor protein (APIP) and compositions thereof. The polypeptides of the subject invention can be used to inhibit the catabolism or sequential cleavage of amyloid beta precursor protein (APP) by sequential cleavage of APP by beta secretase and gamma secretase.
    Type: Grant
    Filed: May 3, 2004
    Date of Patent: November 6, 2007
    Assignee: Serono Genetics Institute S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Human cDNAs and proteins and uses thereof
    Patent number: 7285631
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Grant
    Filed: October 15, 2001
    Date of Patent: October 23, 2007
    Assignee: Serono Genetics Institute S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • GSSP4 polynucleotides and polypeptides and uses thereof
    Patent number: 7223727
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GSSP4 polypeptides have been identified that are believed to be beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing cholesterol levels, body mass, body fat, and for treating metabolic-related diseases and disorders. The metabolic-related diseases or disorders include, but are not limited to, obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, diabetes, glucose intolerance, insulin resistance and hypertension.
    Type: Grant
    Filed: February 7, 2002
    Date of Patent: May 29, 2007
    Assignee: Serono Genetics Institute S.A.
    Inventors: Barbara Chicca, John Chicca, Blake Denison, Frances Yen-Potin, Bernard Bihain, Stephane Bejanin, Hiroaki Tanaka, Severin Jobert, Jean-Yves Giordano, Jean-Baptiste Dumas Milne Edwards
  • Human cDNAs and proteins and uses thereof
    Publication number: 20070015144
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Application
    Filed: May 22, 2002
    Publication date: January 18, 2007
    Applicant: GENSET, S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Human cDNAs and proteins and uses thereof
    Patent number: 7122629
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: October 17, 2006
    Assignee: Serono Genetics Institute SA
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Human cDNAs and proteins and uses thereof
    Publication number: 20060211090
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Application
    Filed: April 27, 2006
    Publication date: September 21, 2006
    Applicant: Serono Genetics Institute S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Human cDNAs and proteins and uses thereof
    Patent number: 7094876
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: August 22, 2006
    Assignee: Serono Genetics Institute SA
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Isolated human vCOL16A1 polypeptide and fragments thereof
    Patent number: 7074901
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Grant
    Filed: August 6, 2001
    Date of Patent: July 11, 2006
    Assignee: Serono Genetics Institute S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Serine carboxypeptidase hx (SCPhx) and compositions thereof
    Patent number: 7074571
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Grant
    Filed: November 13, 2001
    Date of Patent: July 11, 2006
    Assignee: Serono Genetics Institute SA
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Full-length human cdnas encoding potentially secreted proteins
    Publication number: 20060053498
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Application
    Filed: April 18, 2001
    Publication date: March 9, 2006
    Inventors: Stephane Bejanin, Jean-Baptiste Dumas Milne Edwards, Jean-Yves Giordano, Severin Jobert, Hiroaki Tanaka
  • Human cDNAs and proteins and uses thereof
    Patent number: 7005500
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: February 28, 2006
    Assignee: Serono Genetics Institute, Inc.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Plasmin variants and uses thereof
    Patent number: 6989262
    Abstract: The invention concerns plasmin variants. Polynucleotides the disclosed plasmin variants are provided. Additionally, methods of using the plasmin polynucleotides and polynucleotides are provided herein.
    Type: Grant
    Filed: November 13, 2001
    Date of Patent: January 24, 2006
    Assignee: Serono Genetics Institute, S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Human cdnas and proteins and uses thereof
    Publication number: 20050119171
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Application
    Filed: October 15, 2001
    Publication date: June 2, 2005
    Applicant: Genset S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Human cdnas and proteins and uses thereof
    Publication number: 20050118586
    Abstract: The invention concerns NOVEL polynucleotides and polypeptides. Such NOVEL products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal NOVEL expression and/or biological activity and for screening compounds that may be used in the treatment of NOVEL-related disorders.
    Type: Application
    Filed: November 25, 2002
    Publication date: June 2, 2005
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Gssp4 polynucleotides and polypeptides and uses thereof
    Publication number: 20050075285
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GSSP4 polypeptides have been identified that are believed to be beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing cholesterol levels, body mass, body fat, and for treating metabolic-related diseases and disorders. The metabolic-related diseases or disorders envisioned to be treated by the methods of the invention include, but are not limited to: obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, diabetes, glucose intolerance, insulin resistance and hypertension.
    Type: Application
    Filed: February 7, 2002
    Publication date: April 7, 2005
    Inventors: Barbara Bour, John Chicca, Blake Denison, Frances Yen-Potin, Bernard Bihain, Stephane Bejanin, Hiroaki Tanaka, Severin Jobert, Jean-Yves Giordano, Jean-Baptiste Dumas Milne Edwards
  • Human CDNAS and proteins and uses thereof
    Publication number: 20050026182
    Abstract: The invention provides polynucleotides and polypeptides encoding an isolated amyloid inhibitor protein (APIP) and compositions thereof. The polypeptides of the subject invention can be used to inhibit the catabolism or sequential cleavage of amyloid beta precursor protein (APP) by Sequential cleavage of APP by beta secretase and gamma secretase.
    Type: Application
    Filed: May 3, 2004
    Publication date: February 3, 2005
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Isolated amyloid inhibitor protein (APIP) and compositions thereof
    Patent number: 6794363
    Abstract: The invention provides polynucleotides and polypeptides encoding an isolated amyloid inhibitor protein (APIP) and compositions thereof. The polypeptides of the subject invention can be used to inhibit the catabolism or sequential cleavage of arnyloid beta precursor protein (APP) by Sequential cleavage of APP by beta secretase and gamma secretase.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: September 21, 2004
    Assignee: Genset S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Human cDNAs and proteins and uses thereof
    Publication number: 20030198954
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Application
    Filed: November 14, 2001
    Publication date: October 23, 2003
    Applicant: GENSET, S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka